Search

Your search keyword '"Boele, F W"' showing total 19 results
Start Over Author "Boele, F W"
19 results on '"Boele, F W"'

1. International validation study of an EORTC instrument measuring instrumental activities of daily living (IADL) in patients with brain tumours: EORTC IADL-BN32

Author

Oort, Q., Koekkoek, J., Aaronson, N. K., Boele, F. W., Brannan, C., Capela, A., Hjermstad, M., Klein, M., Lips, I, Narita, Y., Pace, A., Petranovic, D., Pichler, J., Reijneveld, J. C., Sato, H., Seidel, C., Shamieh, O., Sikkes, S. A. M., Talacchi, A., Uitdehaag, B. M. J., Urbanic, T., Young, T., Taphoorn, M. J. B., Dirven, L., E&H: Environmental Chemistry and Toxicology, Oral Infections and Inflammation (OII), Clinical Neuropsychology, and Amsterdam Neuroscience - Neurodegeneration

Published
2022
Full Text
View/download PDF

2. PL02.4.A International validation study of an EORTC instrument measuring instrumental activities of daily living (IADL) in patients with brain tumours: EORTC IADL-BN32

Author

Oort, Q, primary, Koekkoek, J, additional, Aaronson, N K, additional, Boele, F W, additional, Brannan, C, additional, Capela, A, additional, Hjermstad, M, additional, Klein, M, additional, Lips, I, additional, Narita, Y, additional, Pace, A, additional, Petranovic, D, additional, Pichler, J, additional, Reijneveld, J C, additional, Sato, H, additional, Seidel, C, additional, Shamieh, O, additional, Sikkes, S A M, additional, Talacchi, A, additional, Uitdehaag, B M J, additional, Urbanic, T, additional, Young, T, additional, Taphoorn, M J B, additional, and Dirven, L, additional

Published
2022
Full Text
View/download PDF

7. P05.65 The caregiver burden in meningioma: long-term results and its effects on caregiver’s health-related quality of life, anxiety and depression

Author

Zamanipoor Najafabadi, A H, van der Meer, P B, Boele, F W, Reijneveld, J C, Taphoorn, M J B, Klein, M, van Furth, W R, Dirven, L, and Peerdeman, S M

Subjects
Poster Presentations
Abstract

BACKGROUND: Various studies in oncological/neurological patients highlight that informal caregivers suffer from a significant disease burden. We aimed to assess the meningioma caregiver burden, and its effects on caregiver’s health-related quality of life (HRQoL), and levels of anxiety and depression. MATERIAL AND METHODS: In a multicentre cross-sectional study informal caregivers of intracranial meningioma patients at a median of 10 years after their last anti-tumour therapy were included. Informal caregivers were family members or close friends and completed the caregiver disease burden scale, SF-36 (HRQoL) and the Hospital Anxiety and Depression Scale. Caregiver burden was assessed as an independent determinant for caregiver’s HRQoL, and levels of anxiety and depression with multivariable analysis correcting for relevant confounders. Participant recruitment is still in progress. RESULTS: 110 informal caregivers were included (mean age: 64.5, female: 37.2%). Informal caregivers reported any caregiver burden in 35.2% of cases, and clinically relevant burden in 15.7%. More specifically, 20.4% of caregivers suffered from stress, 11.2% from social isolation, 13.0% from feelings of disappointment, 21.0% from emotional problems, and 12.0% from environmental factors complicating the care for the patient. The total caregiver burden score was significantly associated with decreased HRQoL on 6/8 scales and 2/2 component scores: physical function (β=-6.53, p=0.071), role limitation due to physical problems (β=-13.62, p=0.041), bodily pain (β=-13.11, p=0.014), social function (β=-11.87, p=0.001), mental health (β=-14.32, p

Published
2018

9. OS4.2 The long-term disease burden of meningioma patients: results on health-related quality of life, cognitive function, anxiety and depression

Author

Zamanipoor Najafabadi, A H, van der Meer, P B, Boele, F W, Reijneveld, J C, Taphoorn, M J B, Klein, M, van Furth, W R, Dirven, L, and Peerdeman, S M

Subjects
Oral Presentations
Abstract

BACKGROUND: Recent systematic reviews reported that meningioma patients have an impaired health-related quality of life (HRQoL) and cognitive function up to 5 years after intervention. We aimed to assess the long-term disease burden of meningioma patients. MATERIAL AND METHODS: In this multicentre cross-sectional study, intracranial meningioma patients at least 5 years (median: 9.9 years) after anti-tumour therapy were included. HRQoL was measured with the generic SF-36 (8 scales and 2 component scores) and the disease-specific EORTC QLQ-BN20 (11 scales/items), and anxiety and depression with the Hospital Anxiety and Depression Scale (HADS: ≤11/21 points is indicative for probable anxiety or depression). Six domains of cognitive function were assessed with a standardised neuropsychological test battery (z-score

Published
2018

Catalog

Books, media, physical & digital resources
See catalog results